ID

14580

Descripción

Real-Life Evidence on Stroke Prevention in SPAF; ODM derived from: https://clinicaltrials.gov/show/NCT02485873

Link

https://clinicaltrials.gov/show/NCT02485873

Palabras clave

Versiones (1)
  1. 22/4/16 22/4/16 -
Subido en

22 de abril de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Atrial Fibrillation (Prevention of Stroke) NCT02485873

Inglés

Eligibility Atrial Fibrillation (Prevention of Stroke) NCT02485873

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age ≥18 years on the day of the first prescription of the study drug (= index date) during study selection window
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis of nvaf on start date of study or anytime during 365 days before this date
Descripción

Atrial Fibrillation | Heart Valves

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004238
UMLS CUI [2]
C0018826
availability of follow-up at least 180 days after the date of the first prescription of study drug within selection window of study (exposure start date)
Descripción

Availability of follow-up | Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0470187
UMLS CUI [1,2]
C1522577
UMLS CUI [2]
C0013230
evidence of patient activity in the database during 90 days before the date of the first prescription of target drug within selection window.
Descripción

Evidence of Patient activity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332120
UMLS CUI [1,2]
C0451369
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with valvular af
Descripción

Atrial Fibrillation | Heart Valves

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004238
UMLS CUI [2]
C0018826
prescriptions of oral anticoagulants (oacs: vka, dabigatran, rivaroxaban) before index date
Descripción

oral anticoagulants | Vitamin K antagonists | dabigatran | rivaroxaban

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0354604
UMLS CUI [2]
C3653316
UMLS CUI [3]
C2348066
UMLS CUI [4]
C1739768
prescription of more than one oac on the index date or switch to another oac during the follow-up period
Descripción

Other oral anticoagulants

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0354604
prescriptions of < 15mg rivaroxaban at index date or during the follow-up period for patients in rivaroxaban cohort
Descripción

rivaroxaban | cohort

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1739768
UMLS CUI [2]
C0599755
Volver a la parte superior de la página

Similar models

Eligibility Atrial Fibrillation (Prevention of Stroke) NCT02485873

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age ≥18 years on the day of the first prescription of the study drug (= index date) during study selection window
boolean
C0001779 (UMLS CUI [1])
Atrial Fibrillation | Heart Valves
Item
diagnosis of nvaf on start date of study or anytime during 365 days before this date
boolean
C0004238 (UMLS CUI [1])
C0018826 (UMLS CUI [2])
Availability of follow-up | Investigational New Drugs
Item
availability of follow-up at least 180 days after the date of the first prescription of study drug within selection window of study (exposure start date)
boolean
C0470187 (UMLS CUI [1,1])
C1522577 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2])
Evidence of Patient activity
Item
evidence of patient activity in the database during 90 days before the date of the first prescription of target drug within selection window.
boolean
C0332120 (UMLS CUI [1,1])
C0451369 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Atrial Fibrillation | Heart Valves
Item
patients with valvular af
boolean
C0004238 (UMLS CUI [1])
C0018826 (UMLS CUI [2])
oral anticoagulants | Vitamin K antagonists | dabigatran | rivaroxaban
Item
prescriptions of oral anticoagulants (oacs: vka, dabigatran, rivaroxaban) before index date
boolean
C0354604 (UMLS CUI [1])
C3653316 (UMLS CUI [2])
C2348066 (UMLS CUI [3])
C1739768 (UMLS CUI [4])
Other oral anticoagulants
Item
prescription of more than one oac on the index date or switch to another oac during the follow-up period
boolean
C0205394 (UMLS CUI [1,1])
C0354604 (UMLS CUI [1,2])
rivaroxaban | cohort
Item
prescriptions of < 15mg rivaroxaban at index date or during the follow-up period for patients in rivaroxaban cohort
boolean
C1739768 (UMLS CUI [1])
C0599755 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial